Related Experiment Videos
Potentiation of Amipaque epileptogenic activity by neuroleptics
Abstract:
Experiments conducted on rabbits confirmed that chlorpromazine potentiates the weak epileptogenic action of Amipaque (metrizamide). Chlorpromazine withdrawal for a period of 48 h suppresses this potentiating effect in the rabbit. Neuroleptic drugs should therefore be avoided in patients examined with Amipaque. In patients under chronic treatment, neuroleptics ought to be discontinued at least 48 h before examination with Amipaque. With the doses and methods used in the present study, diazepam was not as effective as phenobarbital in preventing epilepsy produced by Amipaque. When premidication is needed or when convulsions occur after Amipaque examinations, combined diazepam and phenobarbital therapy ought to be instituted in order to achieve the best control of epileptic reactions.
Insights
Chlorpromazine can increase Amipaque-induced seizures in rabbits, but this effect is lost after 48-hour withdrawal. Combined diazepam and phenobarbital offer the best seizure control when neuroleptics are necessary before Amipaque examinations.
Area of Science:
- Pharmacology
- Neuroscience
- Radiology
Background:
- Amipaque (metrizamide) is a contrast agent used in medical imaging.
- Neuroleptic medications, such as chlorpromazine, can potentially interact with Amipaque.
- Epileptogenic effects of Amipaque have been observed, necessitating careful patient management.
Purpose of the Study:
- To investigate the interaction between chlorpromazine and Amipaque in a rabbit model.
- To determine the efficacy of diazepam and phenobarbital in preventing Amipaque-induced seizures.
- To establish guidelines for neuroleptic drug use in patients undergoing Amipaque examinations.
Main Methods:
- Experiments were conducted on rabbits to assess the epileptogenic effects of Amipaque.
- Chlorpromazine was administered to evaluate its potentiating effect on Amipaque-induced seizures.
- Drug withdrawal periods and pre-medication strategies were investigated.
Main Results:
- Chlorpromazine was confirmed to potentiate the epileptogenic action of Amipaque in rabbits.
- Withdrawal of chlorpromazine for 48 hours abolished its potentiating effect.
- Phenobarbital demonstrated greater efficacy than diazepam in preventing Amipaque-induced seizures.
Conclusions:
- Neuroleptic drugs should be avoided or discontinued at least 48 hours prior to Amipaque examinations.
- Combined diazepam and phenobarbital therapy is recommended for pre-medication or managing post-examination seizures.
- This study provides crucial insights for optimizing patient safety during Amipaque imaging procedures.